AXGN Q2 2018 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+35.7% YoY

Gross Profit

$17M84.9% margin

Operating Income

-$5M-23.4% margin

Net Income

-$7M-36.1% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+19.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$161M

Total Liabilities

$10M

Stockholders' Equity

$151M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$15M	+35.7%
Gross Profit	$17M	$13M	+35.6%
Operating Income	-$5M	-$1M	-233.2%
Net Income	-$7M	-$2M	-260.5%